Summary:
A double-blinded, randomized, placebo controlled study of the efficacy and safety of three doses of orvepitant in subjects with chronic refractory cough.
Qualified Participants Must:
• Be 18 years of age or older
•
Have a diagnosis of CRC or unexplained cough for at least 1 year prior to screening
•
Females must be non-pregnant and non-lactating with no intention of pregnancy during study treatment
•
If female of childbearing potential and committed to consistent and correct use of an acceptable method of birth control
Qualified Participants May Receive:
Can get compensated up to $525, free treatment and doctor consultations with 24hr emergency phone line.